Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 112

Results For "risk"

1504 News Found

Urologists explore the role of robotics, equity, exercise and medicine on bladder cancer
Healthcare | May 16, 2022

Urologists explore the role of robotics, equity, exercise and medicine on bladder cancer

Researchers presented these bladder cancer study findings at the 117th Annual Scientific Meeting of the American Urological Association (AUA)


New report highlights lack of access to assistive technology
Healthcare | May 16, 2022

New report highlights lack of access to assistive technology

WHO and UNICEF call on governments, industry, donors and civil society to fund and prioritize access to assistive products


Erectile dysfunction drugs help prevent death and complications due to heart disease
Healthcare | May 15, 2022

Erectile dysfunction drugs help prevent death and complications due to heart disease

Huntington Medical Research Institutes present first-of-its-kind study examining impact of erectile dysfunction drugs on major adverse cardiovascular events and mortality


Zydus launches Bemdac to treat LDL-Cholesterol
Drug Approval | May 14, 2022

Zydus launches Bemdac to treat LDL-Cholesterol

It is a new class of drug that treats uncontrolled LDLCholesterol, despite the use of a maximum tolerated dose of statins


Boehringer Ingelheim’s signal analytics technology acquired by ArisGlobal
News | May 12, 2022

Boehringer Ingelheim’s signal analytics technology acquired by ArisGlobal

ArisGlobal acquires Boehringer Ingelheim’s Benefit-Risk Analytic System (BRASS), a software solution designed to support causal analysis of drug safety data in a highly regulated environment


OvaCis rapid test to detect ovarian cancer gets CE mark
Drug Approval | May 12, 2022

OvaCis rapid test to detect ovarian cancer gets CE mark

Revolutionary ovarian cancer rapid test available Q4 2022


First patient dosed with antiepileptic drug candidate CB03 in a first-in-human Phase I trial
Biotech | May 12, 2022

First patient dosed with antiepileptic drug candidate CB03 in a first-in-human Phase I trial

CB03 is a candidate drug for the treatment of refractory epilepsy, independently developed by Zhimeng


Emmes launches Advantage eClinical as a standalone cloud-native clinical technology platform
Biotech | May 12, 2022

Emmes launches Advantage eClinical as a standalone cloud-native clinical technology platform

The cloud platform will empower biotech companies and CROs with an integrated solution for clinical data management and is supported by Emmes specialist data management teams


DSM, UNICEF and Sight and Life extend global partnership to address malnutrition
Healthcare | May 11, 2022

DSM, UNICEF and Sight and Life extend global partnership to address malnutrition

The partners also aim to expand their work to Latin America for the first time


New nirsevimab data analyses reinforce efficacy against RSV
Biotech | May 11, 2022

New nirsevimab data analyses reinforce efficacy against RSV

Nirsevimab is the first investigational immunization designed to protect all infants across the RSV season with a single dose